
In this episode of The Peptide Effect, we explore the emerging world of apolipoprotein-targeting peptides and how they’re reshaping the future of cardiovascular and neurological research. Learn how apolipoproteins transport cholesterol throughout the body, why HDL function may be just as important as HDL levels, and how experimental peptides such as 4F, 5A, ATI-5261, FAMP, CN-105, and D6PV are being investigated for their potential to improve cholesterol metabolism, reduce inflammation, protect the brain, and support healthy aging. We’ll also discuss reverse cholesterol transport, ApoA-I, ApoE, ApoC-II, and the role these peptides may play in the future of precision medicine. Whether you’re interested in peptide science, longevity, heart health, or cutting-edge biomedical research, this episode offers a comprehensive introduction to one of the newest frontiers in peptide therapeutics.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?

Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and Access

Thyroid Bioregulators Protocols: What to Use, How to Stack, and What to Expect

Kidney Peptides: The Most Overlooked Bioregulator for Detox, Balance, and Longevity
Free AI-powered recaps of The Peptide Effect and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.